Meeting report: Eleventh International Conference on Hantaviruses.


Journal

Antiviral research
ISSN: 1872-9096
Titre abrégé: Antiviral Res
Pays: Netherlands
ID NLM: 8109699

Informations de publication

Date de publication:
04 2020
Historique:
received: 29 01 2020
accepted: 01 02 2020
pubmed: 19 2 2020
medline: 12 1 2021
entrez: 19 2 2020
Statut: ppublish

Résumé

The 2019 11th International Conference on Hantaviruses (ICH 2019) was organized by the International Society for Hantaviruses (ISH), and held on September 1-4, 2019, at the Irish College, in Leuven, Belgium. These ICHs have been held every three years since 1989. ICH 2019 was attended by 158 participants from 33 countries. The current report summarizes research presented on all aspects of hantavirology: ecology; pathogenesis and immune responses; virus phylogeny, replication and morphogenesis; epidemiology; vaccines, therapeutics and prevention; and clinical aspects and diagnosis.

Identifiants

pubmed: 32068071
pii: S0166-3542(20)30045-0
doi: 10.1016/j.antiviral.2020.104733
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104733

Subventions

Organisme : NIGMS NIH HHS
ID : P30 GM118228
Pays : United States

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Jan Clement (J)

KU Leuven, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, National Reference Center for Hantaviruses, Leuven, Belgium. Electronic address: jan.clement@uzleuven.be.

Clas Ahlm (C)

Division of Infectious Diseases, Department of Clinical Microbiology, Umeå University Hospital, Umeå, Sweden.

Tatjana Avšič-Županc (T)

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Jason Botten (J)

Division of Immunobiology, Department of Medicine, University of Vermont, Burlington, VT, USA.

Kartik Chandran (K)

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.

Colleen B Jonsson (CB)

Department of Microbiology, University of Tennessee-Knoxville, Knoxville, TN, USA.

Hiroaki Kariwa (H)

Laboratory of Public Health, Department of Preventive Medicine, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.

Jonas Klingström (J)

Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

Boris Klempa (B)

Biomedical Research Center of the Slovak Academy of Sciences, Institute of Virology, Bratislava, Slovakia & Institute of Medical Virology, Charité, Universitätsmedizin, Berlin, Germany.

Detlev H Krüger (DH)

Institute of Medical Virology, Charité, Universitätsmedizin, Berlin, Germany.

Herwig Leirs (H)

Evolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.

Dexin Li (D)

National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China.

Mifang Liang (M)

National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China.

Alemka Markotić (A)

Research Department, University Hospital for Infectious Diseases "Dr. Fran Mihaljevic", Zagreb, Croatia.

Anna Papa (A)

Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Connie S Schmaljohn (CS)

United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.

Nicole D Tischler (ND)

Laboratorio de Virología Molecular, Fundación Ciencia & Vida, Santiago, Chile.

Rainer G Ulrich (RG)

Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Insel Riems, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Insel Riems, Germany.

Antti Vaheri (A)

Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Cecilia Vial (C)

Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.

Richard Yanagihara (R)

Department of Pediatrics, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.

Piet Maes (P)

KU Leuven, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, National Reference Center for Hantaviruses, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH